Cases

• Merck Sharp & Dohme Corp et al v JAMP Pharma Corporation

  Counsel to JAMP in NOC action relating to JANUVIA (sitagliptin), a medication used to control high blood sugar in people with type 2 diabetes.

  Sana Halwani, Veronica C. Tsou, Jim Lepore & Cynthia L. Tape | June 1, 2020
• Allergan Inc v JAMP Pharma Corporation

  Counsel to JAMP in NOC action relating to FIBRISTAL (ulipristal), a medication used to treat moderate-to-severe signs and symptoms of uterine fibroids in adult women.

  Sana Halwani, Kaitlin Soye, Cynthia L. Tape & Anna Hucman | April 1, 2020
• Wi-LAN Inc v LG Electronics and LG Electronics Canada

  Counsel to Wi-LAN Inc in a patent infringement action, involving a patent relating to telecommunication networks, handover of devices between base stations in advanced telecommunication networks, and related technologies. This matter also involved allegations related to standards essential patent licensing obligations; determination of a fair, reasonable and non-discriminatory (FRAND) royalty; and claims under the Competition Act. (Prior to joining Lenczner Slaght)

  Jim Lepore | January 24, 2020
• Bayer Inc et al v JAMP Pharma Corporation

  Counsel to JAMP in NOC action relating to XARELTO (rivaroxaban), a medication indicated for prophylaxis of deep vein thrombosis.

  Sana Halwani, Kaitlin Soye, Cynthia L. Tape, Jim Lepore & Anna Hucman | January 1, 2020
• Wi-LAN Inc and Quarterhill Inc v Telus Communications Inc

  Counsel to Quarterhill Inc. and its subsidiary Wi-LAN Inc. in a patent infringement action, involving patents relating to telecommunication networks, bandwidth allocation in advanced telecommunication networks, and related technologies. This matter also engaged standards essential patent obligations and claims under the Competition Act. (Prior to joining Lenczner Slaght)

  Jim Lepore | November 18, 2019
• Wi-LAN Inc and Quarterhill Inc v LG Electronics and LG Electronics Canada

  Counsel to Quarterhill Inc. and its subsidiary Wi-LAN Inc. in a patent infringement action, involving patents relating to telecommunication networks, bandwidth allocation in advanced telecommunication networks, and related technologies. This matter also engaged standards essential patent obligations and claims under the Competition Act. (Prior to joining Lenczner Slaght)

  Jim Lepore | November 18, 2019
• Wi-LAN Inc and Quarterhill Inc v Rogers Communications Canada Inc

  Counsel to Quarterhill Inc. and its subsidiary Wi-LAN Inc. in a patent infringement action, involving patents relating to telecommunication networks, bandwidth allocation in advanced telecommunication networks, and related technologies. This matter also engaged standards essential patent obligations and claims under the Competition Act. (Prior to joining Lenczner Slaght)

  Jim Lepore | November 18, 2019
• Sunovion Pharmaceuticals Canada Inc et al v JAMP Pharma Corporation

  Counsel to JAMP in NOC action relating to LATUDA (lurasidone), an anti-psychotic medication used to treat bipolar depression and schizophrenia.

  Sana Halwani, Cynthia L. Tape, Veronica C. Tsou, Jim Lepore & Anna Hucman | November 1, 2019
• Rovi Guides and TiVo Solutions v Bell Canada

  Counsel to TiVo Solutions and its subsidiary Rovi Guides in a patent infringement action, involving patents relating to interactive television program guides, DVR technology, and related technologies.

  Cynthia L. Tape, Sana Halwani, Andrew Skodyn, Andrew Parley, Paul-Erik Veel, Jonathan Chen, Veronica C. Tsou, Kaitlin Soye, Laurel D. Hogg & Jacqueline Chan | August 1, 2018
• Rovi Guides and TiVo Solutions v Telus Corporation

  Counsel to TiVo Solutions and its subsidiary Rovi Guides in a patent infringement action, involving patents relating to interactive television program guides, DVR technology, and related technologies.

  Cynthia L. Tape, Sana Halwani, Paul-Erik Veel, Andrew Skodyn, Jonathan Chen, Veronica C. Tsou, Kaitlin Soye, Laurel D. Hogg & Jacqueline Chan | August 1, 2018
• Rovi Guides and TiVo Solutions v Videotron

  Counsel to TiVo Solutions and its subsidiary Rovi Guides in a patent infringement action, involving patents relating to interactive television program guides, DVR technology, and related technologies.

  Cynthia L. Tape, Sana Halwani, Andrew Skodyn, Paul-Erik Veel, Jonathan Chen, Veronica C. Tsou, Kaitlin Soye, Laurel D. Hogg & Jacqueline Chan | August 1, 2018
• United American Corp et al v Instagram

  Counsel to Instagram in a patent infringement action relating to methods for the sharing of content on social media.  

  Melanie Baird, Andrew Skodyn & Veronica C. Tsou | April 2, 2018
• United American Corp et al v Facebook

  Counsel to Facebook in a patent infringement action relating to methods for the sharing of content on social media.

  Melanie Baird, Andrew Skodyn & Veronica C. Tsou | April 2, 2018
• Flair Airlines v Gregor LLC

  Counsel to Gregor LLC in a commercial and domain name dispute.  Successfully resisted a motion for interlocutory injunction by having the action dismissed for lack of jurisdiction.

  Sana Halwani & Veronica C. Tsou | March 1, 2018
• Valeant Canada LP v Ranbaxy Pharmaceuticals Canada Inc.

  Counsel to Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Wellbutrin XL (bupropion hydrochloride), a medication used to treat depression.

  Andrew Skodyn, Sana Halwani, Melanie Baird & Laurel D. Hogg | July 7, 2017
• Purdue Canada v Collegium Pharmaceutical Inc.

  Counsel to Collegium Pharmaceutical Inc. against Purdue Pharma in an application under the Patented Medicines (Notice of Compliance) Regulations, as well as a patent infringement action, involving the medicine XTAMPZA ER® (a tamper-resistant oxycodone product used in pain management).

  Sana Halwani | June 28, 2017
• Pharmascience Inc. v Valeant Canada LP

  Counsel to Valeant in an action for damages under section 8 of the PM(NOC) Regulations relating to Sublinox (zolpidem), a medication used to treat insomnia.

  Andrew Skodyn, Sana Halwani, Melanie Baird & Veronica C. Tsou | June 13, 2017
• Valeant Canada LP v Generic Partners Canada Inc.

  Counsel to Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Glumetza (metformin), a medication used to treat type 2 diabetes.

  Andrew Skodyn, Melanie Baird, Sana Halwani & Naomi Metcalfe | June 9, 2017
• Rosseau Asset Management v The Rosseau Group

  Counsel to Rosseau Asset Management  in a trade-mark infringement and passing off action.

  Sana Halwani, Tom Curry, Laurel D. Hogg & Margaret Robbins | May 4, 2017
• Google Inc v Equustek Solutions Inc

  Counsel to Google in an appeal to the Supreme Court of Canada in a novel case regarding the limits to be placed on internet injunctions granted against non-parties.

  William C. McDowell, Scott Rollwagen & Madison Robins | April 30, 2017
• Wyeth Holdings LLC v GlaxoSmithKline Inc.

  Counsel to Wyeth and Pfizer in a patent infringement and impeachment action related to biologic vaccines against meningitis serotype B infection.

  Tom Curry & Paul-Erik Veel | March 16, 2017
• Venngo Inc v Concierge Connection Inc cob as Perkopolis

  Counsel to Venngo in an appeal to the Federal Court of Appeal and a leave to appeal application to the Supreme Court of Canada of a decision relating to trademark infringement and passing off.

  Andrew Skodyn, Melanie Baird, James S.S. Holtom & Sana Halwani | September 21, 2016
• Ferrero SpA v 218587 Ontario Limited

  Counsel to the defendant in a proceeding relating to the sale of food products containing the plaintiff's trademark. Successfully opposed an interlocutory injunction to restrain the sales of those products.

  Ronald G. Slaght & Brian Kolenda | July 3, 2015
• Teva Canada Limited v Pfizer Canada Inc

  Counsel to Pfizer in an action for damages under section 8 of the PM(NOC) Regulations relating to Lyrica (pregabalin), a neuropathic pain drug.  The action proceeded to a five-week trial.

  Tom Curry, Monique Jilesen, Paul-Erik Veel, James S.S. Holtom & Christina Shiels-Singh | January 1, 2015
• AbbVie Corporation v Janssen Inc

  Counsel for Janssen in a patent infringement action relating to Stelara (ustikinumab), a monoclonal antibody product for use in the treatment of psoriasis, among other indications.  This was the first patent infringement trial in Canada relating to a biologic drug.

  Anne E. Posno, Melanie Baird & J. Gwendolyn Ward | May 1, 2014
• International Commercial Arbitration

  Counsel to a patent licensing company in an international commercial arbitration relating to a patent license agreement and related US multi-jurisdictional patent litigation.

  Lawrence E. Thacker | April 10, 2001
• Perfect 10, Inc v Google, Inc

  Counsel for Google in copyright case relating to image search.

  Andrew Parley | December 1, 2000
• A & W Food Services of Canada Inc v McDonald's Restaurants of Canada Ltd

  Counsel to McDonald's in a successful defence at trial of a claim alleging breach of the trade-mark "Chicken Grill" and loss of goodwill. This was the Canadian decision addressing the concept of "reverse confusion".

  Ronald G. Slaght & Nina Bombier | April 19, 2000
• Apotex Inc v Ontario (Minister of Health and Long-term Care)

  Counsel in a judicial review of the Minister's decision not to list Apo-citalopram as interchangeable with Lundbeck's citalopram-containing pharmaceutical product and the listing of Genpharm's Gen-citalopram on Ontario's Drug Benefit Index.

  Lawrence E. Thacker | April 17, 2000
• Robertson v Canwest Publishing, Inc

  Counsel to Canwest Publishing, Inc. in Canadian class proceeding in which plaintiffs alleged copyright infringement in respect of all electronic news and journalistic published content. Successfully resolved proceeding and coordinated first certification for settlement approval and settlement approval of a Canadian class proceeding within the context of an ongoing CCAA proceeding.

  Peter J. Osborne | March 10, 2000
• Hospira Healthcare Corporation v Kennedy Institute of Rheumatology

  Counsel to Janssen in successfully obtaining one of the highest percentage cost awards seen so far in Federal Court litigation, for a total of approximately $3.5 million in costs.

  Veronica C. Tsou | January 1, 2000
• Re Bell Media

  Counsel to Bell Media in a copyright infringement action against VMedia that raised the issue of whether streaming live television over the internet is permissible under the Copyright Act without the copyright owner's consent. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re Aux Sable

  Counsel to Aux Sable related to invalidating key claims of JL Energy’s patent relating to the transportation of natural gas by pipeline. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re Enbridge

  Counsel to Enbridge in patent and trademark infringement case. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Pharmaceutical Companies

  Counsel to pharmaceutical companies on access to information requests. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Consumer Goods Companies

  Counsel to consumer goods companies on Canadian regulatory matters. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re C-fu Foods

  Counsel to C-fu Foods, a novel food company, drafting US provisional patent applications. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Medical Device Companies

  Counsel to medical device companies on clinical trial regulatory matters. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Pharmaceutical Companies

  Counsel to pharmaceutical companies on patent prosecution of Canadian patents. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Pharmaceutical Companies

  Counsel to pharmaceutical companies on patent strategy and regulatory cases. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re Merck

  Counsel to Merck in its patent impeachment actions related to its pneumococcal conjugate vaccine.  (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re Allergan

  Counsel to Allergan related to patent infringement of a generic version of Allergan’s ALPHAGAN® P (0.15%). (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re Allergan

  Counsel to Allergan related to patent infringement of a generic version of Allergan’s cosmetic drug LATISSE®. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Re GlaxoSmithKline

  Counsel to GlaxoSmithKline a patent infringement and impeachment action related to meningitis serotype B vaccines. (Prior to joining Lenczner Slaght)

  Kaitlin Soye | January 1, 2000
• Integrated Intellectual Property Strategy

  Commissioned by Government of Canada (Innovation, Science and Economic Development Canada) to prepare a study and report on strategies to integrate and exploit intellectual property for idea-based enterprises. (Prior to joining Lenczner Slaght)

  Jim Lepore
• Telecommunication Source Code Dispute

  Retained by a rights-holder in a breach of contract and infringement of intellectual property rights dispute related to Voice Over IP (VOIP) technologies. (Prior to joining Lenczner Slaght)

  Jim Lepore